ASX:RSH

RSH.ASX

$0.023
+$0.000 (+0.00%)
Day Range
$0.023 - $0.023
Volume
185.78K
Market Cap
$34.56M
Price Chart
Market Statistics
Open$0.023
Previous Close$0.023
Day High$0.023
Day Low$0.023
Valuation
Market Cap34.56M
Shares Outstanding1.50B
Trading Activity
Volume185.78K
Value Traded4.27K
Bid$0.022 × 3,161,264
Ask$0.023 × 105,000
Latest News
Respiri increases patient enrolments, revenue and conversion rates with streamlined onboarding system
Technology

Respiri increases patient enrolments, revenue and conversion rates with streamlined onboarding system

Healthcare company Respiri (ASX: RSH) delivered strong growth in patient enrolments during the three months to the end of September across its chronic care management, remote patient monitoring, principal care management and transitional care management programs. A total of 2,435 individuals joined the programs, representing a 71% increase on the June quarter, attributed to a […]

2 min read
Imelda Cotton
Imelda Cotton
Weekly wrap: shares rise to a record high on mining optimism
Hot Topics

Weekly wrap: shares rise to a record high on mining optimism

Australian shares just managed to seal a record closing high on Friday, with a strong rally in mining shares managing to offset losses in almost every other sector. By the close of trade, the ASX 200 was up a slim 8.5 points or 0.1% to 8212.2 points, with the index closing just above flat for […]

5 min read
John Beveridge
John Beveridge
Respiri partners with Hawaiian care facilities in remote patient monitoring deal
Technology

Respiri partners with Hawaiian care facilities in remote patient monitoring deal

Medical technology specialist Respiri (ASX: RSH) has once again displayed the diversity of its business offering by reaching agreements to provide remote nursing support to care facilities in Hawaii. The company has entered into two individual remote patient monitoring (RPM) agreements with Liliha and The Care Centre of Honolulu skilled nursing facilities (SNF) in deals […]

1 min read
Colin Hay
Colin Hay
Respiri raises $1.5m to fast-track wheezo commercialisation in multi-billion-dollar US market
Technology

Respiri raises $1.5m to fast-track wheezo commercialisation in multi-billion-dollar US market

Health technology company Respiri (ASX: RSH) has unveiled a A$1.5 million capital raising as it fast-tracks its expansion through the US respiratory health market, which is forecast to be worth US$85 billion by 2026. The funds will be used to accelerate Respiri’s roll-out strategy of its Food and Drug Administration approved wheezo device and software […]

3 min read
Lorna Nicholas
Lorna Nicholas